Related Experiment Video
Updated: Jun 26, 2025
07:27
Robotics in Surgery: A Modular Robotic Platform Driven Gastric Wedge Resection
Published on: February 7, 2025
441
Da Vinci and Hugo RAS Platforms for robot-assisted partial nephrectomy: a preliminary prospective comparative
Esther García Rojo1, Vital Hevia Palacios1, Ricardo Brime Menendez1
1Department of Urology, ROC Clinic, HM Sanchinarro University Hospital, HM Hospitales, Madrid, Spain.
Minerva Urology and Nephrology
|May 17, 2024
Summary
Robot-assisted partial nephrectomy (RAPN) using the Hugo RAS system shows similar outcomes to the Da Vinci system. This study compared both robotic platforms for T1 renal-cell-carcinoma treatment.
Area of Science:
- Urology
- Surgical Oncology
- Robotic Surgery
Background:
- Robot-assisted partial nephrectomy (RAPN) is a standard for T1 renal-cell-carcinoma.
- New robotic platforms, such as Hugo RAS, are emerging.
- Comparative studies are needed to assess their efficacy against established systems like Da Vinci.
Purpose of the Study:
- To compare the perioperative outcomes of robot-assisted partial nephrectomy (RAPN) using the Hugo RAS system versus the Da Vinci system.
- To evaluate the feasibility and safety of the Hugo RAS system in comparison to the Da Vinci system for T1 renal-cell-carcinoma.
Main Methods:
- A prospective, single-center study enrolled 50 patients undergoing RAPN (25 Da Vinci Xi, 25 Hugo RAS).
- Patient demographics, tumor characteristics, operative details, and postoperative outcomes were collected.
- Statistical analyses were performed using SPSS version 22.0.
Main Results:
- No significant differences were observed in median age, sex, or nephrometry scores between the groups.
- While Da Vinci had shorter docking times, console and warm ischemia times were similar.
- Renorraphy times were shorter with Hugo RAS; postoperative outcomes, margin positivity, and major complications (Clavien IIIa) were comparable. Trifecta rates were 88% for Da Vinci and 84% for Hugo RAS.
Conclusions:
- The Hugo RAS system demonstrates similar perioperative outcomes to the Da Vinci system for RAPN.
- Further long-term studies are required to assess oncological and functional results.
